JPMorgan Downgrades ViroPharma (VPHM) to Neutral
Tweet Send to a Friend
JPMorgan downgraded ViroPharma (NASDAQ: VPHM) from Overweight to Neutral.
This article: 48 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 48 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE